Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov-Dec;25(6):1153-1158.
doi: 10.4103/aian.aian_836_22. Epub 2022 Dec 3.

Medication-Adherence and Management of Risk Factors for Secondary Prevention of Stroke Using Smartphone-Based Application: Protocol for MAMORs-Randomized Controlled Trial

Veena Babu  1 , P N Sylaja  2 , Biju Soman  3 , Ravi Prasad Varma  3 , M S Manju  2 , G L Geethu  2 , B Suresh Kumar  4
Affiliations

Medication-Adherence and Management of Risk Factors for Secondary Prevention of Stroke Using Smartphone-Based Application: Protocol for MAMORs-Randomized Controlled Trial

Veena Babu et al. Ann Indian Acad Neurol. 2022 Nov-Dec.

Abstract

Background: In LMICs, the medication adherence and risk factor control are suboptimal in the post-stroke follow-up period. With shortage of physicians, smartphone-based interventions can help stroke survivors in secondary stroke prevention.

Objectives: We aim to validate a digital innovative technology-based intervention to improve the awareness, medication adherence, control of risk factors through timely intervention of physician among the stroke survivors.

Methods: MAMOR is a smartphone-based application to improve the stroke awareness by heath education materials, reminders to timely adherence of medication, alerts on control of risk factors, video files, and timely physician intervention. The study will involve development of the app using contextual research (Delphi qualitative method) followed by a randomized, single center, double arm-controlled trial with 1:1 assignment. The app will be evaluated over a period of 6 months with a target to enroll 192 participants. Process evaluation will be conducted. The sample size was calculated as 192, considering medication adherence of 43.8%, 20% increase in medication adherence by app, power of 80%, and 10% loss to follow-up.

Results: The primary outcome will be medication adherence, changes in the lifestyle and behavioral and control of vascular risk factors. The secondary outcome will include vascular events and functional outcome.

Conclusion: This study will be one among the few studies for secondary prevention of stroke through digital technology innovation in LMICs with resource constraints. The evidences generated from this study will provide translational evidence for other similar settings for stroke survivors.

Keywords: Medication adherence; risk factors; secondary prevention; stroke.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Recruitment of patients in the study
See this image and copyright information in PMC

References

    1. Jones SP, Baqai K, Clegg A, Georgiou R, Harris C, Holland EJ, et al. Stroke in India: A systematic review of the incidence, prevalence, and case fatality. Int J Stroke. 2022;17:132–40. - PMC - PubMed
    1. Shani SD, Varma RP, Sarma PS, Sylaja PN, Kutty VR. Life style and behavioural factors are associated with stroke recurrence among survivors of first episode of stroke: A case control study. J Stroke Cerebrovasc Dis. 2021;30:10560–6. - PubMed
    1. Singh G, Sharma M, Kumar GA, Rao NG, Prasad K, Mathur P, et al. The burden of neurological disorders across the states of India: The Global Burden of Disease Study 1990 -2019. Lancet Glob Health. 2021;9:e1129–44. - PMC - PubMed
    1. Shani SD, Sylaja PN, Sankara Sarma P, Raman Kutty V. Facilitators and barriers to medication adherence among stroke survivors in India. J Clin Neurosci. 2021;88:185–90. - PubMed
    1. Sylaja PN, Singh G, Sivasambath S, Arun K, Jeemon P, Antony R, et al. Secondary prevention of stroke by a primary health care approach: An open-label cluster randomised trial. J Clin Neurosci. 2021;84:53–9. - PubMed